Table 2 Univariate and multivariate Cox regression analyses of MACE
Variables | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
Odds ratio | 95% CI | P-value | Odds ratio | 95% CI | P-value | |
SAF | 2.00 | 1.41–2.78 | < 0.01 | 1.86 | 1.08–3.12 | 0.03 |
Age | 1.03 | 1.01–1.05 | < 0.01 | 1.01 | 0.98–1.04 | 0.67 |
BMI | 0.90 | 0.84–0.97 | < 0.01 | 0.88 | 0.80–0.96 | < 0.01 |
History of CABG | 2.24 | 1.17–4.01 | 0.02 | 1.49 | 0.63–3.38 | 0.35 |
Hemoglobin | 0.77 | 0.67–0.87 | < 0.01 | 0.95 | 0.78–1.15 | 0.58 |
Albumin | 0.54 | 0.30–0.96 | 0.03 | 1.93 | 0.86–4.30 | 0.10 |
eGFR | 0.97 | 0.96–0.98 | < 0.01 | 0.98 | 0.97–0.99 | 0.01 |
HbA1c | 0.94 | 0.65–1.30 | 0.73 | 1.20 | 0.77–1.79 | 0.41 |
Triglyceride | 0.99 | 0.99–1.00- | 0.051 | 0.99 | 0.99–1.00 | 0.15 |
LDL-cholesterol | 0.99 | 0.98–0.99 | 0.01 | 0.98 | 0.97–0.99 | 0.03 |
HDL-cholesterol | 1.00 | 0.98–1.02 | 0.83 | 1.00 | 0.98–1.03 | 0.77 |
BNP | 1.006 | 1.00–1.00 | < 0.01 | 1.00 | 0.99–1.00 | 0.27 |
Aspirin | 1.22 | 0.70–2.09 | 0.47 | 0.54 | 0.27–1.06 | 0.07 |
Statin, | 1.18 | 0.69–2.05 | 0.55 | 1.24 | 0.57–2.69 | 0.59 |
β-Blockers | 2.17 | 1.05–5.28 | 0.04 | 2.00 | 0.82–5.74 | 0.13 |
Oral hypoglycemic agent | 1.09 | 0.50–2.11 | 0.83 | 0.84 | 0.30–2.10 | 0.72 |